CENTRISA 21
CENTRISA 21
Discontinued
DIN Number
02411199
Drug Class
Human
Market Date
N/A
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02411199
AIG Number0636783002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AB11 NORGESTIMATE AND ESTROGEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
ETHINYL ESTRADIOLActive
Strength: 0.035 MG
Monograph: ETHINYL ESTRADIOL
NORGESTIMATEActive
Strength: 0.180 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.215 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.250 MG
Monograph: NORGESTIMATE